7-Dehydrocholesterol (7-DHC) is a subcutaneous sterol and a precursor to various active vitamin D₃. Here, a Saccharomyces cerevisiae strain equipped with the de novo biosynthetic pathway for 7-DHC was constructed. 109.0 mg L^-1 of 7-DHC was achieved initially by introducing heterologous 24-dehydrocholesterol reductase (DHCR24) and overexpressing vital enzymes. Following these modifications, the dynamic regulation of the ergosterol pathway and multicopy expression of DHCR24 resulted in an 86.3% increase in the 7-DHC titer. Subsequently, the effects of several organic solvents and surfactants on 7-DHC production were also explored. The addition of ε-polylysine increased the titer of 7-DHC by 99.1%. Finally, by assembling the pathway in peroxisomes and rebalancing the redox levels, the 7-DHC titer reached 517.4 mg L^-1 in shake flasks. Scale-up fermentation with a 5 L bioreactor demonstrated that 3.26 g L^-1 of 7-DHC was produced. The pathway refactoring strategy provides efficient production of 7-DHC in a sustainable manner.

• PMID: 40575831
• DOI full text
• PubMed
• PubTator

Reference Type

Journal Article

Authors

Han Y, Gao H, Wang S, Ju H, Ge R, Xue C, Liu W, Jiang X, Zhang W

Primary Lit For

Additional Lit For

Review For